Lab
Nations Laboratory Services, LLC
Nations Laboratory Services, LLC was paid $272K by Medicaid between Apr 2019 and Jan 2021, across 7 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 99% of everything it billed.
33Billing provider infoNATIONS LABORATORY SERVICES, LLC
TECUMSEH, OK 74873
TECUMSEH, OK 74873
33aNPI1861976763assigned 09/18/2018
33bProvider typeClinical Medical Laboratory
28Total paid$272K
24GClaims8,666
24DCodes billed7
24AFirst – last monthApr 2019 – Jan 2021
Compared with peers
Next to other Clinical Medical Laboratory providers in Oklahoma
Rank by total paid#23 of 46
Median peer was paid$248K
This provider vs. median1.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 4,844 | $267K | |
| 2020 | 3,787 | $5K | |
| 2021 | 35 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 99% | 4,847 | 756 | $268K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 751 | 624 | $2K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 505 | 488 | $2K |
| 87640 | <1% | 691 | 666 | $610.51 | |
| 87541 | <1% | 692 | 667 | $116.85 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 690 | 665 | $116.85 |
| 87631 | 0% | 490 | 473 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWEDDLE, STEVEN (PRESIDENT/CEO)